首页 > 最新文献

Case Reports in Dermatology最新文献

英文 中文
Multiple Hypertrophic Lichen Planus Mimicking Squamous Cell Carcinoma: A Case Report. 多发性增生性扁平苔藓模拟鳞状细胞癌1例报告。
IF 0.8 Q4 DERMATOLOGY Pub Date : 2026-01-13 eCollection Date: 2026-01-01 DOI: 10.1159/000550461
Sho Hirata, Daisuke Watabe, Toshihide Akasaka, Hiroo Amano

Introduction: Hypertrophic lichen planus (HLP) with pseudoepitheliomatous hyperplasia (PEH) can closely mimic well-differentiated squamous cell carcinoma (SCC), creating a clinically important diagnostic pitfall. Fewer than 26 case reports in the literature describe HLP initially misdiagnosed as SCC, underscoring the need for careful clinicopathologic correlation.

Case presentation: A 77-year-old woman developed multiple hyperkeratotic nodules and plaques on both legs and feet over 4 months. A punch biopsy led to an initial diagnosis of well-differentiated SCC. An additional elliptical incisional biopsy from a separate plaque showed irregular acanthosis with hypergranulosis, endophytic well-differentiated squamous epithelium, and a dense lichenoid interface infiltrate with focal basal vacuolar change and Max-Joseph spaces, without destructive invasion or significant atypia - findings consistent with HLP with PEH. The lesions flattened with topical clobetasol propionate under occlusion for 6 weeks, and no recurrence was observed during a 3-month follow-up.

Conclusion: HLP can closely mimic well-differentiated SCC, making adequate tissue sampling and clinicopathologic correlation essential to avoid unnecessary surgery. This case adds to the limited literature on HLP misdiagnosed as SCC and highlights the need to also consider inflammatory mimickers.

增生性扁平苔藓(HLP)伴假上皮瘤性增生(PEH)与高分化鳞状细胞癌(SCC)非常相似,这是一个重要的临床诊断缺陷。文献中描述HLP最初被误诊为SCC的病例报告少于26例,强调需要仔细的临床病理相关性。病例介绍:一位77岁的女性在4个多月的时间里,在双腿和双脚出现了多个角化结节和斑块。穿孔活检初步诊断为高分化鳞状细胞癌。另一个单独斑块的椭圆切口活检显示不规则棘层伴颗粒增多,内生分化良好的鳞状上皮,致密的地衣样界面浸润伴局灶性基底空泡改变和Max-Joseph间隙,无破坏性侵袭或明显的异型性,与HLP合并PEH一致。局部应用丙酸氯倍他索封堵6周后病变变平,随访3个月未见复发。结论:HLP能很好地模拟高分化SCC,充分的组织取样和临床病理相关性对避免不必要的手术至关重要。本病例增加了关于HLP误诊为SCC的有限文献,并强调需要考虑炎症模拟物。
{"title":"Multiple Hypertrophic Lichen Planus Mimicking Squamous Cell Carcinoma: A Case Report.","authors":"Sho Hirata, Daisuke Watabe, Toshihide Akasaka, Hiroo Amano","doi":"10.1159/000550461","DOIUrl":"https://doi.org/10.1159/000550461","url":null,"abstract":"<p><strong>Introduction: </strong>Hypertrophic lichen planus (HLP) with pseudoepitheliomatous hyperplasia (PEH) can closely mimic well-differentiated squamous cell carcinoma (SCC), creating a clinically important diagnostic pitfall. Fewer than 26 case reports in the literature describe HLP initially misdiagnosed as SCC, underscoring the need for careful clinicopathologic correlation.</p><p><strong>Case presentation: </strong>A 77-year-old woman developed multiple hyperkeratotic nodules and plaques on both legs and feet over 4 months. A punch biopsy led to an initial diagnosis of well-differentiated SCC. An additional elliptical incisional biopsy from a separate plaque showed irregular acanthosis with hypergranulosis, endophytic well-differentiated squamous epithelium, and a dense lichenoid interface infiltrate with focal basal vacuolar change and Max-Joseph spaces, without destructive invasion or significant atypia - findings consistent with HLP with PEH. The lesions flattened with topical clobetasol propionate under occlusion for 6 weeks, and no recurrence was observed during a 3-month follow-up.</p><p><strong>Conclusion: </strong>HLP can closely mimic well-differentiated SCC, making adequate tissue sampling and clinicopathologic correlation essential to avoid unnecessary surgery. This case adds to the limited literature on HLP misdiagnosed as SCC and highlights the need to also consider inflammatory mimickers.</p>","PeriodicalId":9619,"journal":{"name":"Case Reports in Dermatology","volume":"18 1","pages":"89-95"},"PeriodicalIF":0.8,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12880845/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146140654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emergence of Vitiligo during Treatment with Risankizumab-Rzaa for Plaque Psoriasis: A Case Report. 利尚单抗- rzaa治疗斑块型银屑病期间出现白癜风1例报告
IF 0.8 Q4 DERMATOLOGY Pub Date : 2025-12-20 eCollection Date: 2026-01-01 DOI: 10.1159/000548980
Kevin V Thomas, Jennifer M Tran, Lisa M Cotter

Introduction: Risankizumab-rzaa (Skyrizi) is a humanized monoclonal antibody (IgG1) approved for the treatment of severe plaque psoriasis. It selectively blocks the p19 subunit of the IL-23 pathway, leading to reduced keratinocyte proliferation reducing the inflammatory response.

Case presentation: We present a case of de novo vitiligo in a patient being treated with risankizumab-rzaa (Skyrizi) for plaque psoriasis. Our patient had extensive plaque psoriasis affecting his trunk, upper extremities, and scalp, encompassing 30% of his total body surface area. He was treated with risankizumab-rzaa, an IL-23 inhibitor, with significant improvement of his psoriasis and residual hyperpigmented, post-inflammatory patches. In addition, he developed new-onset vitiligo, for which he declined treatment and was continued on risankizumab-rzaa. On subsequent follow-up over a year later, there were extensive areas of vitiligo now with a trichrome pattern suggestive of active vitiligo.

Conclusion: To our knowledge, no cases of de novo vitiligo associated with risankizumab-rzaa have been reported in the literature, and our patient may represent the first reported case. The role of IL-23 remains unclear, and our case represents the importance of further research to better elucidate IL-23's role in vitiligo.

Risankizumab-rzaa (Skyrizi)是一种人源化单克隆抗体(IgG1),被批准用于治疗重度斑块型银屑病。它选择性阻断IL-23通路的p19亚基,导致角质形成细胞增殖减少,从而降低炎症反应。病例介绍:我们报告了一例新发白癜风的患者正在接受瑞尚单抗-rzaa (Skyrizi)治疗斑块型银屑病。我们的病人有广泛的斑块银屑病,影响他的躯干、上肢和头皮,占他全身表面积的30%。他接受了IL-23抑制剂risankizumab-rzaa治疗,他的银屑病和残留的色素沉着、炎症后斑块明显改善。此外,他出现了新发白癜风,他拒绝治疗并继续服用瑞尚单抗-rzaa。在一年后的后续随访中,白癜风大面积出现三色图案,提示白癜风活动性。结论:据我们所知,文献中尚未报道与risankizumab-rzaa相关的新生白癜风病例,该患者可能是第一例报道病例。IL-23在白癜风中的作用尚不清楚,我们的病例表明进一步研究IL-23在白癜风中的作用具有重要意义。
{"title":"Emergence of Vitiligo during Treatment with Risankizumab-Rzaa for Plaque Psoriasis: A Case Report.","authors":"Kevin V Thomas, Jennifer M Tran, Lisa M Cotter","doi":"10.1159/000548980","DOIUrl":"10.1159/000548980","url":null,"abstract":"<p><strong>Introduction: </strong>Risankizumab-rzaa (Skyrizi) is a humanized monoclonal antibody (IgG1) approved for the treatment of severe plaque psoriasis. It selectively blocks the p19 subunit of the IL-23 pathway, leading to reduced keratinocyte proliferation reducing the inflammatory response.</p><p><strong>Case presentation: </strong>We present a case of de novo vitiligo in a patient being treated with risankizumab-rzaa (Skyrizi) for plaque psoriasis. Our patient had extensive plaque psoriasis affecting his trunk, upper extremities, and scalp, encompassing 30% of his total body surface area. He was treated with risankizumab-rzaa, an IL-23 inhibitor, with significant improvement of his psoriasis and residual hyperpigmented, post-inflammatory patches. In addition, he developed new-onset vitiligo, for which he declined treatment and was continued on risankizumab-rzaa. On subsequent follow-up over a year later, there were extensive areas of vitiligo now with a trichrome pattern suggestive of active vitiligo.</p><p><strong>Conclusion: </strong>To our knowledge, no cases of de novo vitiligo associated with risankizumab-rzaa have been reported in the literature, and our patient may represent the first reported case. The role of IL-23 remains unclear, and our case represents the importance of further research to better elucidate IL-23's role in vitiligo.</p>","PeriodicalId":9619,"journal":{"name":"Case Reports in Dermatology","volume":"18 1","pages":"64-69"},"PeriodicalIF":0.8,"publicationDate":"2025-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12823106/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146028440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metastatic Syringocystadenocarcinoma Papilliferum Treated with Enzalutamide: A Case Report and a Review of the Literature. 恩杂鲁胺治疗转移性乳头状囊腺癌1例报告及文献复习。
IF 0.8 Q4 DERMATOLOGY Pub Date : 2025-12-12 eCollection Date: 2026-01-01 DOI: 10.1159/000548401
Antonino Colloca, Domenico Michele D'Angiolella, Gabriele Laezza, Chiara Cesaro, Maria Cristina Giugliano, Filippo Sepe, Francesco Caraglia, Miriam Forte, Silvana Cozzolino, Alfonso Esposito, Vincenzo Terrano, Andrea Ronchi, Francesca Pagliuca, Vincenzo De Falco, Stefania Napolitano, Teresa Troiani, Lorenzo Lobianco

Introduction: Syringocystadenocarcinoma papilliferum (SCACP) is a rare malignancy of the elderly originating from apocrine adnexal glands, mostly developing in the head and neck district. To date, there is no established treatment for metastatic SCACP, leaving affected patients with small therapeutic opportunities.

Case presentation: Herein, it is described the case of a 70-year-old man affected by metastatic SCACP, treated with three different sequential therapy lines: carboplatin plus paclitaxel, epirubicin, and an off-label protocol with enzalutamide, achieving 41 months overall survival. Off-label enzalutamide treatment has been justified by androgen receptor expression by SCACP cells, a common feature of apocrine glands derived tumors. Interestingly, SCACP demonstrated to be responsive to enzalutamide treatment, even though the patient precociously stopped the treatment due to severe toxicity.

Conclusion: This case represents the first evidence of hormonotherapy administration in a SCACP patient, possibly providing the base for a new therapeutic opportunity for this rare malignancy.

摘要:乳头状囊腺癌(SCACP)是一种罕见的老年人恶性肿瘤,起源于大汗腺,主要发生在头颈部。到目前为止,对于转移性SCACP没有确定的治疗方法,使得受影响的患者治疗机会很小。病例介绍:本文描述了一名70岁男性转移性SCACP的病例,接受三种不同的顺序治疗线:卡铂加紫杉醇、表柔比星和说明书外方案enzalutamide,总生存期为41个月。经SCACP细胞雄激素受体表达证实,说明书外的enzalutamide治疗是合理的,SCACP细胞是大汗腺源性肿瘤的共同特征。有趣的是,SCACP对enzalutamide治疗有反应,即使患者因严重毒性而过早停止治疗。结论:该病例是SCACP患者接受激素治疗的第一个证据,可能为这种罕见恶性肿瘤的新治疗机会提供基础。
{"title":"Metastatic Syringocystadenocarcinoma Papilliferum Treated with Enzalutamide: A Case Report and a Review of the Literature.","authors":"Antonino Colloca, Domenico Michele D'Angiolella, Gabriele Laezza, Chiara Cesaro, Maria Cristina Giugliano, Filippo Sepe, Francesco Caraglia, Miriam Forte, Silvana Cozzolino, Alfonso Esposito, Vincenzo Terrano, Andrea Ronchi, Francesca Pagliuca, Vincenzo De Falco, Stefania Napolitano, Teresa Troiani, Lorenzo Lobianco","doi":"10.1159/000548401","DOIUrl":"10.1159/000548401","url":null,"abstract":"<p><strong>Introduction: </strong>Syringocystadenocarcinoma papilliferum (SCACP) is a rare malignancy of the elderly originating from apocrine adnexal glands, mostly developing in the head and neck district. To date, there is no established treatment for metastatic SCACP, leaving affected patients with small therapeutic opportunities.</p><p><strong>Case presentation: </strong>Herein, it is described the case of a 70-year-old man affected by metastatic SCACP, treated with three different sequential therapy lines: carboplatin plus paclitaxel, epirubicin, and an off-label protocol with enzalutamide, achieving 41 months overall survival. Off-label enzalutamide treatment has been justified by androgen receptor expression by SCACP cells, a common feature of apocrine glands derived tumors. Interestingly, SCACP demonstrated to be responsive to enzalutamide treatment, even though the patient precociously stopped the treatment due to severe toxicity.</p><p><strong>Conclusion: </strong>This case represents the first evidence of hormonotherapy administration in a SCACP patient, possibly providing the base for a new therapeutic opportunity for this rare malignancy.</p>","PeriodicalId":9619,"journal":{"name":"Case Reports in Dermatology","volume":"18 1","pages":"25-31"},"PeriodicalIF":0.8,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12795547/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145964930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Familial Annular Erythema Effectively Responded to Phototherapy: A Case Report of an Extremely Rare Entity and Literature Review. 家族性环状红斑对光疗有效:一罕见病例报告及文献复习。
IF 0.8 Q4 DERMATOLOGY Pub Date : 2025-12-11 eCollection Date: 2026-01-01 DOI: 10.1159/000549976
Waseem Alhawsawi, Houriah Nukaly, Abdulhadi Jfri, Razan S Al-Luhaibi, Abdulmajeed Aljarallah, Sarah M Fageeh, Khalid Al Hawsawi

Introduction: Familial annular erythema is the inherited form of erythema annular centrifugum, in an autosomal dominant fashion. It is an extremely rare cutaneous condition characterized by asymptomatic or mildly itchy annular, arcuate or polycyclic erythematous plaques that appears few days after birth with no systemic manifestations. Histopathological features are consistent with erythema annular centrifugum. To this date, only five families have been reported to the literature.

Case presentation: Herein, we report a family with three generations of affected individuals. The index patient was a 23-year-old female, presented with mildly itchy non-scaly annular and arcuate erythematous plaques that appeared since birth. Her paternal grandmother, father, sister and two male cousins have similar condition. Review of system and laboratory workup was unremarkable. Skin biopsy showed focal compact orthohyperkeratosis, spongiosis, basal cell degeneration, prominent papillary edema with moderate superficial and deep perivascular eosinophilic infiltrate. The index patient was started on narrowband ultraviolet B therapy and showed complete clearance for at least 3 months.

Conclusion: This extremely rare entity is not known to be associated with other organ involvement, apart from the skin. It poses diagnostic difficulty as it resembles other annular conditions during infancy. The presence of similar cases within her family underscores the genetic component of this condition, warranting further investigation and discussion. Possible effective therapeutic options include phototherapy.

简介:家族性环形红斑是一种常染色体显性遗传病。这是一种极其罕见的皮肤病,其特征是无症状或轻度发痒的环状、弓形或多环状红斑斑块,在出生后几天出现,无全身表现。组织病理学特征与离心环形红斑一致。到目前为止,文献中只报道了五个家族。病例介绍:在此,我们报告一个三代患病的家庭。第一例患者为23岁女性,出生后出现轻度瘙痒、无鳞片的环形和弓形红斑斑块。她的祖母、父亲、妹妹和两个堂兄弟也有类似的情况。系统审查和实验室检查不显著。皮肤活检显示局灶性致密性角化过度症,海绵状病变,基底细胞变性,突出的乳头状水肿伴中度浅表和深部血管周围嗜酸性粒细胞浸润。指数患者开始窄带紫外线B治疗,显示完全清除至少3个月。结论:这种极其罕见的实体不知道与其他器官受累,除了皮肤。它造成诊断困难,因为它类似于婴儿期的其他环状疾病。在其家族中存在类似病例,强调了这种情况的遗传成分,需要进一步调查和讨论。可能有效的治疗选择包括光疗。
{"title":"Familial Annular Erythema Effectively Responded to Phototherapy: A Case Report of an Extremely Rare Entity and Literature Review.","authors":"Waseem Alhawsawi, Houriah Nukaly, Abdulhadi Jfri, Razan S Al-Luhaibi, Abdulmajeed Aljarallah, Sarah M Fageeh, Khalid Al Hawsawi","doi":"10.1159/000549976","DOIUrl":"10.1159/000549976","url":null,"abstract":"<p><strong>Introduction: </strong>Familial annular erythema is the inherited form of erythema annular centrifugum, in an autosomal dominant fashion. It is an extremely rare cutaneous condition characterized by asymptomatic or mildly itchy annular, arcuate or polycyclic erythematous plaques that appears few days after birth with no systemic manifestations. Histopathological features are consistent with erythema annular centrifugum. To this date, only five families have been reported to the literature.</p><p><strong>Case presentation: </strong>Herein, we report a family with three generations of affected individuals. The index patient was a 23-year-old female, presented with mildly itchy non-scaly annular and arcuate erythematous plaques that appeared since birth. Her paternal grandmother, father, sister and two male cousins have similar condition. Review of system and laboratory workup was unremarkable. Skin biopsy showed focal compact orthohyperkeratosis, spongiosis, basal cell degeneration, prominent papillary edema with moderate superficial and deep perivascular eosinophilic infiltrate. The index patient was started on narrowband ultraviolet B therapy and showed complete clearance for at least 3 months.</p><p><strong>Conclusion: </strong>This extremely rare entity is not known to be associated with other organ involvement, apart from the skin. It poses diagnostic difficulty as it resembles other annular conditions during infancy. The presence of similar cases within her family underscores the genetic component of this condition, warranting further investigation and discussion. Possible effective therapeutic options include phototherapy.</p>","PeriodicalId":9619,"journal":{"name":"Case Reports in Dermatology","volume":"18 1","pages":"70-80"},"PeriodicalIF":0.8,"publicationDate":"2025-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12863736/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146112040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dermatofibroma with Hypopigmented Meyerson Halo: A Case Report and Review of Non-Melanocytic Hosts. 皮肤纤维瘤伴低色素迈耶森晕:非黑素细胞宿主1例报告及回顾。
IF 0.8 Q4 DERMATOLOGY Pub Date : 2025-12-10 eCollection Date: 2026-01-01 DOI: 10.1159/000549986
Mohammed Shanshal, Muna M Abuayyash

Introduction: Meyerson phenomenon denotes a perilesional, classically eczematous halo around a pre-existing lesion, most often melanocytic. Non-melanocytic halos are uncommon and can mimic regression in a melanocytic lesion, including melanoma, leading to urgent referrals.

Case presentation: We report a 37-year-old woman with a "mole with a halo" on her arm. Examination revealed a 5-mm pink papule with a thin whitish collarette and a faint, ill-defined hypopigmented ring. Dermoscopy showed a structureless pink centre with a pinpoint crust and delicate collarette, but no pigment network or organised vascular pattern. Excisional biopsy revealed a dermal spindle-cell proliferation characteristic of dermatofibroma; the diagnosis was confirmed by negative SOX10 and positive Factor XIIIa staining. Notably, there was no spongiotic perilesional dermatitis. A targeted literature review confirmed the rarity of halos around dermatofibromas, which are typically eczematous.

Conclusion: Our case expands the clinicopathologic spectrum to include a hypopigmented, non-eczematous Meyerson-like ("forme-fruste") halo variant and supports a dermoscopy-first approach to avoid over-triage to melanoma and help streamline care.

简介:Meyerson现象是指病灶周围的典型湿疹晕,通常是黑素细胞。非黑素细胞光晕是不常见的,可以模仿黑素细胞病变的消退,包括黑色素瘤,导致紧急转诊。病例介绍:我们报告一位37岁的女性,她的手臂上有一颗“带光环的痣”。检查发现一个5毫米的粉红色丘疹,有一个淡白色的小圈和一个模糊的低色素环。皮肤镜显示无结构的粉红色中心,有针状外壳和精致的结缔组织,但没有色素网络或有组织的血管模式。切除活检显示皮肤纤维瘤的梭形细胞增生特征;SOX10染色阴性,XIIIa染色阳性。值得注意的是,没有海绵性皮炎。一项有针对性的文献综述证实了皮肤纤维瘤周围的光晕的罕见性,这是典型的湿疹。结论:我们的病例扩展了临床病理谱,包括色素沉着,非湿疹meyerson样(“形成-斑块”)光晕变异,并支持皮肤镜优先方法,以避免过度分类为黑色素瘤,并有助于简化护理。
{"title":"Dermatofibroma with Hypopigmented Meyerson Halo: A Case Report and Review of Non-Melanocytic Hosts.","authors":"Mohammed Shanshal, Muna M Abuayyash","doi":"10.1159/000549986","DOIUrl":"10.1159/000549986","url":null,"abstract":"<p><strong>Introduction: </strong>Meyerson phenomenon denotes a perilesional, classically eczematous halo around a pre-existing lesion, most often melanocytic. Non-melanocytic halos are uncommon and can mimic regression in a melanocytic lesion, including melanoma, leading to urgent referrals.</p><p><strong>Case presentation: </strong>We report a 37-year-old woman with a \"mole with a halo\" on her arm. Examination revealed a 5-mm pink papule with a thin whitish collarette and a faint, ill-defined hypopigmented ring. Dermoscopy showed a structureless pink centre with a pinpoint crust and delicate collarette, but no pigment network or organised vascular pattern. Excisional biopsy revealed a dermal spindle-cell proliferation characteristic of dermatofibroma; the diagnosis was confirmed by negative SOX10 and positive Factor XIIIa staining. Notably, there was no spongiotic perilesional dermatitis. A targeted literature review confirmed the rarity of halos around dermatofibromas, which are typically eczematous.</p><p><strong>Conclusion: </strong>Our case expands the clinicopathologic spectrum to include a hypopigmented, non-eczematous Meyerson-like (\"forme-fruste\") halo variant and supports a dermoscopy-first approach to avoid over-triage to melanoma and help streamline care.</p>","PeriodicalId":9619,"journal":{"name":"Case Reports in Dermatology","volume":"18 1","pages":"56-63"},"PeriodicalIF":0.8,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12818893/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146017224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pseudoephedrine-Associated Erythromelalgia: A Case Report of a Rare Drug Reaction. 伪麻黄碱相关性红斑性肢痛症:一例罕见药物反应报告。
IF 0.8 Q4 DERMATOLOGY Pub Date : 2025-12-09 eCollection Date: 2026-01-01 DOI: 10.1159/000549963
Liang Zhi Wong, Georgios Kravvas

Introduction: Erythromelalgia is a rare disorder characterized by severe burning extremity pain, erythema, and increased skin temperature. Symptoms are aggravated by warming and alleviated by cooling. It is known to be associated with multiple underlying conditions, as well as reactions in response to medications.

Case presentation: A 38-year-old man experienced two distinct episodes of redness and swelling of his hands after taking "cold" tablets containing paracetamol and pseudoephedrine. His symptoms peaked 72 h after onset despite discontinuing the medication. Upon being made aware that there was an association between pseudoephedrine and erythromelalgia, he avoided all pseudoephedrine-containing medications with no recurrence.

Conclusion: This case represents the second documented report of pseudoephedrine-associated erythromelalgia in the literature, with a proposed direct link due to the sympathetic adrenergic effects of pseudoephedrine on the vasculature.

红斑性肢痛是一种罕见的疾病,其特征是严重的四肢灼痛、红斑和皮肤温度升高。升温会加重症状,降温会减轻症状。已知它与多种潜在疾病以及对药物的反应有关。病例介绍:一名38岁男子在服用含有扑热息痛和伪麻黄碱的“冷”片后,双手出现两次明显的发红和肿胀。他的症状在发病72小时后达到高峰,尽管他已停止用药。在意识到伪麻黄碱与红斑性肢痛症之间存在关联后,他避免了所有含伪麻黄碱的药物,没有复发。结论:该病例是文献中第二例与伪麻黄碱相关的红斑性肢痛症的文献报道,其直接联系是由于伪麻黄碱对脉管系统的交感肾上腺素能作用。
{"title":"Pseudoephedrine-Associated Erythromelalgia: A Case Report of a Rare Drug Reaction.","authors":"Liang Zhi Wong, Georgios Kravvas","doi":"10.1159/000549963","DOIUrl":"10.1159/000549963","url":null,"abstract":"<p><strong>Introduction: </strong>Erythromelalgia is a rare disorder characterized by severe burning extremity pain, erythema, and increased skin temperature. Symptoms are aggravated by warming and alleviated by cooling. It is known to be associated with multiple underlying conditions, as well as reactions in response to medications.</p><p><strong>Case presentation: </strong>A 38-year-old man experienced two distinct episodes of redness and swelling of his hands after taking \"cold\" tablets containing paracetamol and pseudoephedrine. His symptoms peaked 72 h after onset despite discontinuing the medication. Upon being made aware that there was an association between pseudoephedrine and erythromelalgia, he avoided all pseudoephedrine-containing medications with no recurrence.</p><p><strong>Conclusion: </strong>This case represents the second documented report of pseudoephedrine-associated erythromelalgia in the literature, with a proposed direct link due to the sympathetic adrenergic effects of pseudoephedrine on the vasculature.</p>","PeriodicalId":9619,"journal":{"name":"Case Reports in Dermatology","volume":"18 1","pages":"51-55"},"PeriodicalIF":0.8,"publicationDate":"2025-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12810974/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145997438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human Metapneumovirus Infection Manifesting as Skin Eruption and Hand Swelling: A Case Report. 人偏肺病毒感染表现为皮肤出疹和手部肿胀1例。
IF 0.8 Q4 DERMATOLOGY Pub Date : 2025-12-08 eCollection Date: 2026-01-01 DOI: 10.1159/000549921
Nouf Almagushi, Rahaf Bashihab, Aljohara Alkhenaizan, Sultan Al-Khenaizan

Introduction: Human metapneumovirus (HMPV) is a respiratory pathogen that affects both children and adults and can be severe in the elderly and immunocompromised hosts. The virus usually results in a spectrum of respiratory illnesses. There is growing evidence that HMPV is also responsible for a variety of skin eruptions.

Case presentation: An immunocompromised 7-year-old patient with HMPV infection is presented with a severe skin eruption and painful swelling of the hand requiring hospital admission.

Conclusion: HMPV-linked skin manifestations should be included in the differential diagnosis in the event of the appearance of a skin eruption in a young child.

人偏肺病毒(HMPV)是一种呼吸道病原体,可感染儿童和成人,在老年人和免疫功能低下的宿主中可能很严重。这种病毒通常会导致一系列呼吸道疾病。越来越多的证据表明HMPV也是多种皮肤爆发的原因。病例介绍:一名免疫功能低下的7岁HMPV感染患者出现严重的皮肤出疹和手部疼痛肿胀,需要住院。结论:hmpv相关的皮肤表现应包括在鉴别诊断的情况下出现的皮肤疹在一个年幼的孩子。
{"title":"Human Metapneumovirus Infection Manifesting as Skin Eruption and Hand Swelling: A Case Report.","authors":"Nouf Almagushi, Rahaf Bashihab, Aljohara Alkhenaizan, Sultan Al-Khenaizan","doi":"10.1159/000549921","DOIUrl":"10.1159/000549921","url":null,"abstract":"<p><strong>Introduction: </strong>Human metapneumovirus (HMPV) is a respiratory pathogen that affects both children and adults and can be severe in the elderly and immunocompromised hosts. The virus usually results in a spectrum of respiratory illnesses. There is growing evidence that HMPV is also responsible for a variety of skin eruptions.</p><p><strong>Case presentation: </strong>An immunocompromised 7-year-old patient with HMPV infection is presented with a severe skin eruption and painful swelling of the hand requiring hospital admission.</p><p><strong>Conclusion: </strong>HMPV-linked skin manifestations should be included in the differential diagnosis in the event of the appearance of a skin eruption in a young child.</p>","PeriodicalId":9619,"journal":{"name":"Case Reports in Dermatology","volume":"18 1","pages":"32-35"},"PeriodicalIF":0.8,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12799231/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145970509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combined Renuvion and Endolift Therapy Suggests Enhanced Skin Tightening Compared to Monotherapy in Upper Arm Rejuvenation: A Case Report. 联合renvion和endollift治疗与单一治疗相比,上臂年轻化可增强皮肤紧致:一例报告。
IF 0.8 Q4 DERMATOLOGY Pub Date : 2025-12-05 eCollection Date: 2026-01-01 DOI: 10.1159/000549556
Mohammadali Nilforoushzadeh, Tannaz Fakhim, Seyedeh Nasim Mirbahari, Shohreh Rafiei, Mohammad Hasan Shahverdi, Rozhin Enamzadeh

Introduction: Skin laxity, a common esthetic concern, drives demand for non-surgical solutions. Energy-based devices like Renuvion® (helium plasma/radiofrequency) and Endolift® (1,470 nm diode laser) offer minimally invasive tightening, yet their combined efficacy remains underexplored. This study evaluates synergistic effects of Renuvion® and Endolift® through an intra-patient comparison.

Case presentation: A 44-year-old female with moderate upper arm laxity underwent Renuvion® alone on the right arm and combined Renuvion® + Endolift® on the left. Endolift® (6 W, 50 ms ON/OFF pulses, 600 μm fiber) delivered 4,000 J-5,000 J per arm via subdermal scraping. Renuvion® followed 1 week later, using standard subdermal settings. Outcomes were assessed via laxity scoring, circumferential measurements, blinded practitioner evaluations, and patient feedback at 8 weeks. The combination arm demonstrated a higher reduction in circumference (34.3% vs. 28.8%) and superior practitioner ratings (3/3 vs. 2/3), indicating enhanced skin tightening. Blinded practitioners rated the left arm's improvement as "marked" (score 3/3) vs. "moderate" (score 2/3) for the right. Patient satisfaction aligned with objective metrics, citing the left arm as "tighter" and "more contoured." No adverse events occurred.

Conclusion: Combining Renuvion® and Endolift® enhanced skin tightening compared to Renuvion® monotherapy, which may suggest synergistic subdermal remodeling. This dual-modality approach may optimize outcomes in fibrous anatomical regions, though larger controlled studies are warranted.

简介:皮肤松弛,一个常见的审美问题,推动非手术解决方案的需求。基于能量的设备,如Renuvion®(氦等离子体/射频)和Endolift®(1,470 nm二极管激光)提供微创收紧,但它们的联合疗效仍有待探索。本研究通过患者内部比较来评估Renuvion®和Endolift®的协同效应。病例介绍:44岁女性,上臂中度松弛,右臂单用Renuvion®,左臂联合Renuvion®+ Endolift®。Endolift®(6 W, 50 ms开/关脉冲,600 μm纤维)通过皮下刮擦,每只手臂提供4,000 J-5,000 J。Renuvion®在1周后使用标准皮下设置进行随访。通过松弛度评分、周向测量、盲法医生评估和患者8周反馈来评估结果。联合治疗组的围度缩小幅度更大(34.3% vs 28.8%),医生评分更高(3/3 vs 2/3),表明皮肤紧致性增强。盲法练习者将左臂的改善评价为“明显”(得分3/3)。右侧为“中等”(2/3分)。患者满意度与客观指标一致,认为左臂“更紧”、“更匀称”。无不良事件发生。结论:Renuvion®联合Endolift®与Renuvion®单药相比,可增强皮肤紧致性,可能提示皮下重塑协同作用。这种双模方法可以优化纤维解剖区域的结果,尽管更大的对照研究是必要的。
{"title":"Combined Renuvion and Endolift Therapy Suggests Enhanced Skin Tightening Compared to Monotherapy in Upper Arm Rejuvenation: A Case Report.","authors":"Mohammadali Nilforoushzadeh, Tannaz Fakhim, Seyedeh Nasim Mirbahari, Shohreh Rafiei, Mohammad Hasan Shahverdi, Rozhin Enamzadeh","doi":"10.1159/000549556","DOIUrl":"https://doi.org/10.1159/000549556","url":null,"abstract":"<p><strong>Introduction: </strong>Skin laxity, a common esthetic concern, drives demand for non-surgical solutions. Energy-based devices like Renuvion<sup>®</sup> (helium plasma/radiofrequency) and Endolift<sup>®</sup> (1,470 nm diode laser) offer minimally invasive tightening, yet their combined efficacy remains underexplored. This study evaluates synergistic effects of Renuvion<sup>®</sup> and Endolift<sup>®</sup> through an intra-patient comparison.</p><p><strong>Case presentation: </strong>A 44-year-old female with moderate upper arm laxity underwent Renuvion<sup>®</sup> alone on the right arm and combined Renuvion<sup>®</sup> + Endolift<sup>®</sup> on the left. Endolift<sup>®</sup> (6 W, 50 ms ON/OFF pulses, 600 μm fiber) delivered 4,000 J-5,000 J per arm via subdermal scraping. Renuvion<sup>®</sup> followed 1 week later, using standard subdermal settings. Outcomes were assessed via laxity scoring, circumferential measurements, blinded practitioner evaluations, and patient feedback at 8 weeks. The combination arm demonstrated a higher reduction in circumference (34.3% vs. 28.8%) and superior practitioner ratings (3/3 vs. 2/3), indicating enhanced skin tightening. Blinded practitioners rated the left arm's improvement as \"marked\" (score 3/3) vs. \"moderate\" (score 2/3) for the right. Patient satisfaction aligned with objective metrics, citing the left arm as \"tighter\" and \"more contoured.\" No adverse events occurred.</p><p><strong>Conclusion: </strong>Combining Renuvion<sup>®</sup> and Endolift<sup>®</sup> enhanced skin tightening compared to Renuvion<sup>®</sup> monotherapy, which may suggest synergistic subdermal remodeling. This dual-modality approach may optimize outcomes in fibrous anatomical regions, though larger controlled studies are warranted.</p>","PeriodicalId":9619,"journal":{"name":"Case Reports in Dermatology","volume":"18 1","pages":"81-88"},"PeriodicalIF":0.8,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12875656/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146140622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
When Sexually Transmitted Infection Treatment Fails: A Rare Dermatological Presentation of Lung Cancer - A Case Report. 当性传播感染治疗失败:一个罕见的皮肤病肺癌-一个病例报告。
IF 0.8 Q4 DERMATOLOGY Pub Date : 2025-12-05 eCollection Date: 2026-01-01 DOI: 10.1159/000549924
Mine Dereli, Ceyda Tetik Aydogdu, Emine Tugba Alatas, Suzan Demir Pektas

Introduction: Cutaneous metastases are uncommon but may represent the first clinical manifestation of internal malignancies. In men, lung cancer is the most frequent source of such lesions. Due to their variable presentation, these metastases can mimic sexually transmitted infections and delay the correct diagnosis.

Case presentation: A 46-year-old male presented with a painless ulcerative lesion in the right inguinal region that had persisted for 1 month. Despite broad-spectrum antibiotic therapy, there was no clinical improvement. Histopathological and immunohistochemical evaluation of a skin biopsy revealed positivity for CK7 and TTF-1, consistent with metastatic lung adenocarcinoma. Subsequent imaging and bronchoscopic biopsy confirmed non-mucinous adenocarcinoma of the lung.

Conclusion: This case highlights the importance of considering internal malignancies in the differential diagnosis of genital and inguinal ulcerative lesions, particularly when conventional treatments fail. Early biopsy and immunohistochemical analysis are essential for accurate diagnosis and timely management.

简介:皮肤转移并不常见,但可能是内部恶性肿瘤的首要临床表现。在男性中,肺癌是这种病变最常见的来源。由于表现多变,这些转移瘤可以模拟性传播感染,并延迟正确诊断。病例介绍:46岁男性,右腹股沟区无痛性溃疡病变持续1个月。尽管广谱抗生素治疗,没有临床改善。皮肤活检的组织病理学和免疫组织化学评估显示CK7和TTF-1阳性,与转移性肺腺癌一致。随后的影像学检查和支气管镜活检证实为肺非粘液腺癌。结论:本病例强调了在生殖器和腹股沟溃疡性病变的鉴别诊断中考虑内部恶性肿瘤的重要性,特别是当常规治疗失败时。早期活检和免疫组织化学分析是准确诊断和及时治疗的必要条件。
{"title":"When Sexually Transmitted Infection Treatment Fails: A Rare Dermatological Presentation of Lung Cancer - A Case Report.","authors":"Mine Dereli, Ceyda Tetik Aydogdu, Emine Tugba Alatas, Suzan Demir Pektas","doi":"10.1159/000549924","DOIUrl":"10.1159/000549924","url":null,"abstract":"<p><strong>Introduction: </strong>Cutaneous metastases are uncommon but may represent the first clinical manifestation of internal malignancies. In men, lung cancer is the most frequent source of such lesions. Due to their variable presentation, these metastases can mimic sexually transmitted infections and delay the correct diagnosis.</p><p><strong>Case presentation: </strong>A 46-year-old male presented with a painless ulcerative lesion in the right inguinal region that had persisted for 1 month. Despite broad-spectrum antibiotic therapy, there was no clinical improvement. Histopathological and immunohistochemical evaluation of a skin biopsy revealed positivity for CK7 and TTF-1, consistent with metastatic lung adenocarcinoma. Subsequent imaging and bronchoscopic biopsy confirmed non-mucinous adenocarcinoma of the lung.</p><p><strong>Conclusion: </strong>This case highlights the importance of considering internal malignancies in the differential diagnosis of genital and inguinal ulcerative lesions, particularly when conventional treatments fail. Early biopsy and immunohistochemical analysis are essential for accurate diagnosis and timely management.</p>","PeriodicalId":9619,"journal":{"name":"Case Reports in Dermatology","volume":"18 1","pages":"45-50"},"PeriodicalIF":0.8,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12803526/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145988094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HLA-B27-Positive Leprosy Masquerading as Peripheral Spondyloarthritis: A Case Report. hla - b27阳性麻风病伪装成周围性脊柱炎1例报告。
IF 0.8 Q4 DERMATOLOGY Pub Date : 2025-11-29 eCollection Date: 2026-01-01 DOI: 10.1159/000549460
Qian Peng, Afang Xu, Qijing Xiao, Xiaobing Wang

Introduction: Leprosy, caused by Mycobacterium leprae, is primarily characterized by cutaneous and peripheral nerve involvement. Nonetheless, musculoskeletal manifestations are also frequently observed and are commonly misdiagnosed as rheumatic diseases.

Case presentation: We report a case of lepromatous leprosy presenting with chronic arthritis and HLA-B27 positivity, which was misdiagnosed as peripheral spondyloarthritis in the early stage due to the absence of typical clinical manifestations.

Conclusion: Lepromatous leprosy may mimic peripheral spondyloarthritis, especially with HLA-B27 positivity. Clinicians should consider leprosy in refractory arthritis or neuropathy, even in non-endemic areas, to prevent disability and transmission.

简介:由麻风分枝杆菌引起的麻风,主要以皮肤和周围神经受累为特征。尽管如此,肌肉骨骼表现也经常被观察到,并常被误诊为风湿病。病例介绍:我们报告一例以慢性关节炎和HLA-B27阳性为表现的麻风型麻风患者,由于缺乏典型的临床表现,早期被误诊为周围性脊柱炎。结论:麻风性麻风可能与周围性脊柱炎相似,特别是HLA-B27阳性。临床医生应考虑难治性关节炎或神经病变的麻风病,即使在非流行地区,以防止残疾和传播。
{"title":"HLA-B27-Positive Leprosy Masquerading as Peripheral Spondyloarthritis: A Case Report.","authors":"Qian Peng, Afang Xu, Qijing Xiao, Xiaobing Wang","doi":"10.1159/000549460","DOIUrl":"10.1159/000549460","url":null,"abstract":"<p><strong>Introduction: </strong>Leprosy, caused by <i>Mycobacterium leprae</i>, is primarily characterized by cutaneous and peripheral nerve involvement. Nonetheless, musculoskeletal manifestations are also frequently observed and are commonly misdiagnosed as rheumatic diseases.</p><p><strong>Case presentation: </strong>We report a case of lepromatous leprosy presenting with chronic arthritis and HLA-B27 positivity, which was misdiagnosed as peripheral spondyloarthritis in the early stage due to the absence of typical clinical manifestations.</p><p><strong>Conclusion: </strong>Lepromatous leprosy may mimic peripheral spondyloarthritis, especially with HLA-B27 positivity. Clinicians should consider leprosy in refractory arthritis or neuropathy, even in non-endemic areas, to prevent disability and transmission.</p>","PeriodicalId":9619,"journal":{"name":"Case Reports in Dermatology","volume":"18 1","pages":"11-17"},"PeriodicalIF":0.8,"publicationDate":"2025-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12755893/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145888587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Case Reports in Dermatology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1